IP Library Assignment 063214/0108
Patent Assignment
Reel/Frame 063214/0108

Confirmatory Grant of Security Interest in United States Patents

Recorded: 2023-03-31 Pages: 31
Assignors
PACIRA CRYOTECH, INC.
Executed: 2023-03-31
PACIRA PHARMACEUTICALS, INC.
Executed: 2023-03-31
Assignee
JPMORGAN CHASE BANK, N.A.
10 S DEARBORN ST., CHICAGO, ILLINOIS, 60603
Covered Properties (137)
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations and Processes for Making the Same
Application: 17/344,039 →
Publication: US US20210299047A1
Zinc Meloxicam Complex Microparticles and Anesthetic Formulations and Processes for Making the Same
Application: 17/360,927 →
Publication: US US20210322316A1
Multivesicular Liposome Formulations of Dexmedetomidine
Application: 17/625,705 →
Publication: US US20220273568A1
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/319,591 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/719,716 →
Publication: US US20220233447A1
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/720,166 →
Publication: US US20220233448A1
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/840,104 →
Publication: US US20220304932A1
Compositions of Bupivacaine Multivesicular Liposomes
Application: 17/932,243 →
Publication: US US20230248648A1
Multivesicular Liposome Formulations of Dexamethasone
Application: 18/046,312 →
Publication: US US20230137783A1
Bupivacaine Multivesicular Liposome Formulations and Uses Thereof
Application: 18/046,416 →
Publication: US US20230133849A1
Uses of Bupivacaine Multivesicular Liposomes as Stellate Ganglion Block
Application: 18/171,831 →
Publication: US US20230277516A1
Uses of Bupivacaine Multivesicular Liposomes as Stellate Ganglion Block for Treating Anxiety Disorders
Application: 63/383,177 →
Treatment of Pain by Subarachnoid Administration of Sustained-Release Liposomal Anesthetic Compositions
Application: 17/958,780 →
Publication: US US20230038098A1
Treatment of Pain Associated with Cesarean Section Surgery with Sustained-Release Liposomal Anesthetic Compositions
Application: 18/071,160 →
Publication: US US20230087140A1
Treatment of Pain by Administration of Sustained-Release Liposomal Anesthetic Compositions
Application: 17/958,678 →
Publication: US US20230042662A1
Treatment of Pain by Subarachnoid Administration of Sustained-Release Liposomal Anesthetic Compositions
Application: 17/790,426 →
Publication: US US20230080593A1
Treatment of Pain in Pediatric Patients by Administration of Sustained-Release Liposomal Anesthetic Compositions
Application: 17/697,261 →
Publication: US US20220387318A1
Treatment of Hip Pain with Sustained-Release Liposomal Anesthetic Compositions
Application: 17/684,805 →
Publication: US US20220218613A1
Treatment of Hip Pain with Sustained-Release Liposomal Anesthetic Compositions
Application: 17/572,248 →
Publication: US US20220218610A1
Treatment of Hip Pain with Sustained-Release Liposomal Anesthetic Compositions
Application: 17/746,249 →
Publication: US US20220273564A1
Adenoviral-Based Biological Delivery and Expression System for Use in the Treatment of Osteoarthritis
Application: 17/497,045 →
Publication: US US20220073948A1
Adenoviral- Based Biological Delivery and Expression System for Use in the Treatment of Osteoarthritis
Application: 17/855,322 →
Publication: US US20220348963A1
Sustained Release Thermosetting Gels Comprising Sodium Channel Blockers and the Methods of Making Same
Application: 17/640,090 →
Publication: US US20220296719A1
Effective Dosages of an Adenoviral-Based Biological Delivery and Expression System for Use in the Treatment of Osteoarthritis in Humans, and Compositions Comprising the Same
Application: 17/760,715 →
Publication: US US20220403415A1
IL-1Ra GENE THERAPY FOR INTERVERTEBRAL DISC DEGENERATION
Application: 17/821,761 →
Publication: US US20230158170A1
Compositions and Methods for Improved Adenoviral- Based Gene Therapy Utilizing Corticosteroid Treatment
Application: 63/488,130 →
Extended-Release Triamcinolone Acetonide for Treating Osteoarthritis Pain in Subjects with Diabetes
Application: 63/488,910 →
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (FAT)
Application: 16/440,798 →
Publication: US US20190290347A1
Dermal and Transdermal Cryogenic Microprobe Systems
Application: 17/193,406 →
Publication: US US20210186585A1
Pain Management Using Cryogenic Remodeling
Application: 15/888,979 →
Publication: US US20180235805A1
Cryogenic Needle With Freeze Zone Regulation
Application: 16/259,609 →
Publication: US US20190151006A1
Cryogenic Blunt Dissection Methods and Devices
Application: 17/140,334 →
Publication: US US20210128219A1
Secure Cryosurgical Treatment System
Application: 17/091,366 →
Publication: US US20210077174A1
Cryogenic Enhancement of Joint Function, Alleviation of Joint Stiffness and/or Alleviation of Pain Associated With Osteoarthritis
Application: 16/783,821 →
Publication: US US20200206024A1
Methods, Systems, and Devices for Treating Nerve Spasticity
Application: 17/571,307 →
Publication: US US20220125630A1
Methods and Systems for Preventing Neuroma Formations
Application: 17/591,492 →
Publication: US US20220151673A1
Methods and Systems for Locating and Treating Nerves With Cold Therapy
Application: 17/700,036 →
Publication: US US20220280218A1
Integrated Cold Therapy and Electrical Stimulation Systems for Locating and Treating Nerves and Associated Methods
Application: 17/464,545 →
Publication: US US20210393309A1
Cryogenic Device With Quick-Connect Needle Probes
Application: 17/081,437 →
Publication: US US20210121219A1
Display Device and Interfaces for Cryogenic Devices
Application: 17/096,491 →
Publication: US US20210157472A1
Cryogenic Devices With Venting Features
Application: 17/108,690 →
Publication: US US20210161579A1
Stabilizing Pressure in Cryogenic Devices
Application: 17/102,757 →
Publication: US US20210161577A1
Cryogenic Device
Patent: 995,802 →
Application: 29/780,705 →
Dock for a Cryogenic Device
Patent: 990,671 →
Application: 29/780,346 →
Display Screen with Graphical User Interface for a Cryogenic Device
Patent: 1,034,629 →
Application: 29/780,337 →
Sustained Release Formulation of Methotrexate as a Disease-Modifying Antirheumatic Drug (Dmard) and an Anti-Cancer Agent
Patent: 9,770,414 →
Application: 12/914,944 →
Publication: US US20110280932A1
Sustained Release Formulation of Methotrexate as a Disease-Modifying Antirheumatic Drug (Dmard) and an Anti-Cancer Agent
Application: 13/786,323 →
Publication: US US20130183370A1
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,724,302 →
Application: 13/786,378 →
Publication: US US20130177635A1
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Application: 13/786,873 →
Publication: US US20130177636A1
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,757,336 →
Application: 13/786,945 →
Publication: US US20130183373A1
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,737,483 →
Application: 13/787,117 →
Publication: US US20130177638A1
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,737,482 →
Application: 13/786,933 →
Publication: US US20130183372A1
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,808,424 →
Application: 13/791,569 →
Publication: US US20130183375A1
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Patent: 9,730,892 →
Application: 15/249,195 →
Publication: US US20160361260A1
Method for Formulating Large Diameter Synthetic Membrane Vesicles
Application: 15/676,151 →
Publication: US US20180092847A1
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/283,450 →
Publication: US US20120114740A1
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/787,480 →
Publication: US US20130183374A1
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Patent: 9,974,744 →
Application: 13/787,265 →
Publication: US US20130209547A1
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/787,382 →
Publication: US US20130209548A1
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/787,462 →
Publication: US US20130189348A1
Sustained Release Formulation of a Non-Steroidal Anti-Inflammatory Drug
Application: 13/790,279 →
Publication: US US20130189350A1
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations and Processes for Making the Same
Application: 15/816,916 →
Publication: US US20180161275A1
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations and Processes for Making the Same
Application: 16/919,741 →
Publication: US US20200397699A1
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/156,400 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/319,956 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/536,516 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/536,478 →
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/156,424 →
Compositions of Bupivacaine Multivesicular Liposomes
Application: 17/590,636 →
Publication: US US20220233442A1
Compositions of Bupivacaine Multivesicular Liposomes
Application: 17/748,933 →
Publication: US US20220280426A1
Manufacturing of Bupivacaine Multivesicular Liposomes
Application: 17/156,385 →
Enantiomers of Spiro-Oxindole Compounds and Their Uses as Therapeutic Agents
Patent: 8,450,358 →
Application: 12/825,168 →
Publication: US US20100331386A1
Enantiomers of Spiro-Oxindole Compounds and Their Uses as Therapeutic Agents
Patent: 9,480,677 →
Application: 14/510,634 →
Publication: US US20150025121A1
Synthetic Methods for Spiro-Oxindole Compounds
Patent: 8,445,696 →
Application: 12/904,880 →
Publication: US US20110087027A1
Synthetic Methods for Spiro-Oxindole Compounds
Patent: 9,260,446 →
Application: 14/272,297 →
Publication: US US20140336390A1
Pharmaceutical Compositions of Spiro-Oxindole Compound for Topical Administration and Their Use as Therapeutic Agents
Patent: 9,504,671 →
Application: 13/580,129 →
Publication: US US20130143941A1
Corticosteroids for the Treatment of Joint Pain
Patent: 9,949,987 →
Application: 15/459,961 →
Publication: US US20170182068A1
Corticosteroids for the Treatment of Joint Pain
Patent: 9,555,047 →
Application: 14/461,883 →
Publication: US US20150025050A1
Corticosteroids for the Treatment of Joint Pain
Patent: 9,555,048 →
Application: 14/461,884 →
Publication: US US20140356437A1
Corticosteroids for the Treatment of Joint Pain
Patent: 8,828,440 →
Application: 13/422,994 →
Publication: US US20120288534A1
Corticosteroids for the Treatment of Joint Pain
Application: 15/937,053 →
Publication: US US20180311260A1
Adenoviral-based biological delivery and expression system for use in the treatment of Osteoarthritis
Application: 14/375,351 →
Publication: US US20150031083A1
Asymmetric Syntheses for Spiro-Oxindole Compounds Useful as Therapeutic Agents
Patent: 9,487,535 →
Application: 13/794,147 →
Publication: US US20130274483A1
Methods of Treating Postherpetic Neuralgia with a Topical Formulation of a Spiro-Oxindole Compound
Patent: 9,682,033 →
Application: 15/016,921 →
Publication: US US20160228354A1
Asymmetric Synthesis of Funapide
Application: 15/625,173 →
Publication: US US20180002341A1
Solid State Forms of Spiro-Oxindole Compounds
Application: 15/625,724 →
Publication: US US20180016283A1
Solid State Forms of Spiro-Oxindole Compounds
Application: 16/156,718 →
Publication: US US20190071449A1
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (Fat)
Patent: 7,713,266 →
Application: 11/295,204 →
Publication: US US20070129714A1
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (Fat)
Patent: 7,850,683 →
Application: 11/770,185 →
Publication: US US20080183164A1
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (Fat)
Patent: 7,862,558 →
Application: 12/399,598 →
Publication: US US20090171334A1
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (Fat)
Patent: 7,998,137 →
Application: 12/758,686 →
Publication: US US20100198207A1
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (Fat)
Patent: 9,345,526 →
Application: 13/178,451 →
Publication: US US20120065629A1
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (Fat)
Application: 15/148,539 →
Publication: US US20160354133A1
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (Fat)
Application: 16/795,951 →
Publication: US US20200188005A1
Subdermal Cryogenic Remodeling of Muscles, Nerves, Connective Tissue, and/or Adipose Tissue (Fat)
Patent: 9,072,498 →
Application: 12/948,659 →
Publication: US US20110144631A1
Dermal and Transdermal Cryogenic Microprobe Systems
Patent: 9,254,162 →
Application: 11/614,887 →
Publication: US US20080154254A1
Dermal and Transdermal Cryogenic Microprobe Systems
Application: 14/982,728 →
Publication: US US20160183996A1
Replaceable and/or Easily Removable Needle Systems for Dermal and Transdermal Cryogenic Remodeling
Patent: 8,409,185 →
Application: 11/675,886 →
Publication: US US20080200910A1
Replaceable and/or Easily Removable Needle Systems for Dermal and Transdermal Cryogenic Remodeling
Patent: 9,113,855 →
Application: 13/786,407 →
Publication: US US20130324990A1
Pain Management Using Cryogenic Remodeling
Patent: 8,298,216 →
Application: 12/271,013 →
Publication: US US20090248001A1
Pain Management Using Cryogenic Remodeling
Patent: 8,715,275 →
Application: 13/615,059 →
Publication: US US20130218148A1
Pain Management Using Cryogenic Remodeling
Patent: 9,101,346 →
Application: 14/042,679 →
Publication: US US20140249519A1
Pain Management Using Cryogenic Remodeling
Patent: 9,907,693 →
Application: 14/795,648 →
Publication: US US20160000601A1
Pain Management Using Cryogenic Remodeling
Application: 16/796,078 →
Publication: US US20200214885A1
Pain Management Using Cryogenic Remodeling
Application: 16/796,047 →
Publication: US US20200188165A1
Subdermal Tissue Remodeling Using Myostatin, Methods and Related Systems
Patent: 8,461,108 →
Application: 12/400,698 →
Publication: US US20090226424A1
Integrated Cryosurgical System with Refrigerant and Electrical Power Source
Patent: 9,066,712 →
Application: 13/255,102 →
Publication: US US20120265278A1
Method for Reducing Hyperdynamic Facial Wrinkles
Patent: 9,039,688 →
Application: 13/325,004 →
Publication: US US20120265187A1
Skin Protection for Subdermal Cryogenic Remodeling for Cosmetic and Other Treatments
Patent: 9,241,753 →
Application: 13/741,350 →
Publication: US US20130184695A1
Skin Protection for Subdermal Cryogenic Remodeling for Cosmetic and Other Treatments
Application: 14/968,053 →
Publication: US US20160095643A1
Cryogenic Needle with Freeze Zone Regulation
Patent: 9,314,290 →
Application: 13/741,360 →
Publication: US US20130184696A1
Cryogenic Needle With Freeze Zone Regulation
Application: 15/065,685 →
Publication: US US20160183998A1
Cryogenic Probe Filtration System
Patent: 9,155,584 →
Application: 13/741,363 →
Publication: US US20130184694A1
Cryogenic Probe System and Method
Patent: 9,017,318 →
Application: 13/747,436 →
Publication: US US20130190745A1
Handheld device
Patent: 702,848 →
Application: 29/421,240 →
Dock
Patent: 683,733 →
Application: 29/421,239 →
Handheld device and dock
Patent: 732,739 →
Application: 29/421,237 →
Cryogenic Blunt Dissection Methods and Devices
Application: 15/893,178 →
Publication: US US20180168709A1
Secure Cryosurgical Treatment System
Application: 14/534,120 →
Publication: US US20150126988A1
Secure Cryosurgical Treatment System
Application: 16/168,551 →
Publication: US US20190125423A1
Methods and Devices for Pain Management
Patent: 9,295,512 →
Application: 14/025,527 →
Publication: US US20140276539A1
Cryogenic Enhancement of Joint Function, Alleviation of Joint Stiffness and/or Alleviation of Pain Associated with Osteoarthritis
Patent: 9,610,112 →
Application: 14/218,167 →
Publication: US US20140343543A1
Methods and Devices for Pain Management
Application: 15/045,797 →
Publication: US US20160166429A1
Cryogenic Enhancement of Joint Function, Alleviation of Joint Stiffness and/or Alleviation of Pain Associated with Osteoarthritis
Application: 15/454,762 →
Publication: US US20170239086A1
Methods and Systems for Treatment of Occipital Neuralgia
Application: 14/218,901 →
Publication: US US20140343544A1
Methods and Systems for Treatment of Occipital Neuralgia
Application: 15/457,642 →
Publication: US US20170258510A1
Methods and Systems for Treatment of Occipital Neuralgia
Application: 16/121,386 →
Publication: US US20190090927A1
Methods, Systems, and Devices for Treating Neuromas, Fibromas, Nerve Entrapment, and/or Pain Associated Therewith
Application: 14/218,146 →
Publication: US US20140343542A1
Methods, Systems, and Devices for Treating Neuromas, Fibromas, Nerve Entrapment, and/or Pain Associated Therewith
Application: 16/132,205 →
Publication: US US20190038459A1
Methods and Systems for Treatment of Spasticity
Patent: 9,668,800 →
Application: 14/218,925 →
Publication: US US20140276708A1
Methods and Systems for Preventing Neuroma Formations
Application: 15/069,790 →
Publication: US US20160262820A1
Methods and Systems for Preventing Neuroma Formations
Application: 16/592,331 →
Publication: US US20200030016A1
Methods and Systems for Locating and Treating Nerves with Cold Therapy
Application: 15/594,238 →
Publication: US US20180116705A1
Integrated Cold Therapy and Electrical Stimulation Systems for Locating and Treating Nerves and Associated Methods
Application: 16/191,660 →
Publication: US US20190142494A1
Tip Assembly for a Cryogenic Device
Patent: 977,094 →
Application: 29/780,339 →
Bupivacaine Multivesicular Liposome Formulations and Uses Thereof
Uses of Bupivacaine Multivesicular Liposomes as Stellate Ganglion Block
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 20, 2021
From: HALL, JEFFREY S.; TURNBULL, DAVID J.; GRIGSBY, JOHN J., JR.; ARDEKANI, SOROUSH M.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 057537/0020 →
Supplemental Confirmatory Grant of Security Interest in United States Patents Dec 14, 2021
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; FLEXION THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058516/0636 →
Assignment of Assignor's Interest Feb 9, 2022
From: SLONIN, JONATHAN H.; WINSTON, ROY; DYSART, STAN
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 058979/0964 →
Assignment of Assignor's Interest Apr 1, 2022
From: SLONIN, JONATHAN H.; WINSTON, ROY; DYSART, STAN
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 059571/0962 →
Assignment of Assignor's Interest Apr 7, 2022
From: WINSTON, ROY
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 059530/0784 →
Assignment of Assignor's Interest May 31, 2022
From: SLONIN, JONATHAN H.; WINSTON, ROY; DYSART, STAN
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 060221/0267 →
Assignment of Assignor's Interest Jul 11, 2022
From: WINSTON, ROY
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 060469/0659 →
Assignment of Assignor's Interest Jul 11, 2022
From: LOS, KATHY; KHARITONOV, VLADIMIR
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 060469/0001 →
Assignment of Assignor's Interest Jul 11, 2022
From: WINSTON, ROY
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 060469/0637 →
Assignment of Assignor's Interest Oct 6, 2022
From: WINSTON, ROY
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 061332/0361 →
Assignment of Assignor's Interest Oct 6, 2022
From: WINSTON, ROY
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 061332/0394 →
Assignment of Assignor's Interest Oct 6, 2022
From: LOS, KATHY; KHARITONOV, VLADIMIR
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 061332/0724 →
Assignment of Assignor's Interest Oct 6, 2022
From: LOS, KATHY; KHARITONOV, VLADIMIR
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 061331/0961 →
Assignment of Assignor's Interest Oct 6, 2022
From: LOS, KATHY; KHARITONOV, VLADIMIR
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 061331/0949 →
Assignment of Assignor's Interest Oct 7, 2022
From: HALL, JEFFREY S.; TURNBULL, DAVID J.; GRIGSBY, JOHN J., JR.; ARDEKANI, SOROUSH M.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 061350/0918 →
Assignment of Assignor's Interest Nov 3, 2022
From: DAVIS, PAIGE N.; ARDEKANI, SOROUSH M.; KURZ, STEPHANIE M.; GARCIA, LOUIE D.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 061642/0834 →
Assignment of Assignor's Interest Nov 3, 2022
From: GARCIA, LOUIE D.; ARDEKANI, SOROUSH M.; DAVIS, PAIGE N.; KURZ, STEPHANIE M.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 061642/0784 →
Assignment of Assignor's Interest Dec 8, 2022
From: LOS, KATHY; KHARITONOV, VLADIMIR
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 062027/0631 →
Assignment of Assignor's Interest Dec 8, 2022
From: WINSTON, ROY; SCRANTON, RICHARD
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 062027/0517 →
Assignment of Assignor's Interest Dec 8, 2022
From: WINSTON, ROY; SCRANTON, RICHARD
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 062027/0457 →
Assignment of Assignor's Interest Jan 26, 2023
From: GARCIA, LOUIE D.; ARDEKANI, SOROUSH M.; DAVIS, PAIGE N.; KURZ, STEPHANIE M.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 062496/0264 →
Termination and Release of Security Interest in Patents Mar 31, 2023
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 063213/0864 →
Assignment of Assignor's Interest Mar 31, 2023
From: ARDEKANI, SOROUSH M.; BOEN, PATRICK GHL; GARCIA, LOUIE D.; DAVIS, PAIGE N.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 063194/0861 →
Assignment of Assignor's Interest Mar 31, 2023
From: HALL, JEFFREY S.; TURNBULL, DAVID J.; ARDEKANI, SOROUSH M.; LOS, KATHLEEN D.A.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 063195/0001 →
Assignment of Assignor's Interest Mar 31, 2023
From: HALL, JEFFREY S.; TURNBULL, DAVID J.; GRIGSBY, JOHN J., JR.; ARDEKANI, SOROUSH M.
To: PACIRA PHARMACEUTICALS, INC.
Reel/Frame 063195/0036 →